Roche selecteert Veeva Development Cloud-applicaties
Toonaangevend farmaceutisch bedrijf selecteert Veeva Vault-toepassingen op klinisch, regelgevend en kwaliteitsniveau
BARCELONA, Spanje – (BUSINESS WIRE) – Veeva Systems (NYSE: VEEV) heeft vandaag aangekondigd dat Roche (SWX: ROG) wereldwijd Veeva Development Cloud-applicaties heeft geselecteerd om klinische, regelgevende en kwaliteitsprocessen te stroomlijnen. Het bedrijf schakelt over naar uniforme applicaties in Vault Clinical, Vault RIM, en Vault Quality-suites om de efficiëntie te verhogen, de gegevenskwaliteit te verbeteren en de compliance te stimuleren gedurende de hele levenscyclus van het product.
“Het versnellen van de ontwikkeling van geneesmiddelen en het leveren van producten zijn strategische prioriteiten voor innovatieve life sciences-bedrijven zoals Roche”, zegt Rik van Mol, vice-president van Veeva Development Cloud. “Veeva Development Cloud breekt systeem- en processilo’s af, zodat life sciences-bedrijven sneller innovatieve behandelingen aan patiënten kunnen bieden.”
Roche Selects Veeva Development Cloud Applications
Leading pharmaceutical company selects Veeva Vault applications across clinical, regulatory, and quality
BARCELONA, Spain–(BUSINESS WIRE)– Veeva Systems (NYSE: VEEV) today announced that Roche (SWX: ROG) has selected Veeva Development Cloud applications globally to streamline clinical, regulatory, and quality processes. The company is switching to unified applications in Vault Clinical, Vault RIM, and Vault Quality suites to increase efficiency, enhance data quality, and drive compliance throughout the product lifecycle.
“Speeding drug development and product supply are strategic priorities for innovative life sciences companies like Roche,” said Rik Van Mol, vice president of Veeva Development Cloud. “Veeva Development Cloud breaks down system and process silos so life sciences companies can more quickly bring innovative treatments to patients.”
Roche is standardizing on clinical applications Vault eTMF and Vault CTMS, regulatory applications Vault Submissions, Vault Registrations, and Vault Submissions Archive, and quality applications Vault QMS and Vault QualityDocs.
Learn more about Veeva Vault Development Cloud at the upcoming Veeva R&D and Quality Summit, October 13-14, 2020. The virtual event is open to life sciences industry professionals. Register and stay up to date on program details at veeva.com/Summit.
Additional Information
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud solutions—including data, software, and services—for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 900 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. The company is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com/eu.
Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
® 2020 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc.
Veeva Systems Inc. owns other registered and unregistered trademarks.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201012005167/en/
Contacts
Roger Villareal
Veeva Systems
925-264-8885
Deivis Mercado
Veeva Systems
925-226-8821